Awde Probiotics GI
Natural health product licensed in Canada
- Other names
- Intensive GI Probiotics, Probiotics
- Licence holder
- 10933872 Canada Inc.
- NPN or DIN-HM
- 80128802
- Status
- Active licence
- Licence date
- 8 January 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactiplantibacillus plantarum Source : KABP-023 | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : KABP-022 | 1 Milliards d'UFC | Not calculated |
| Pediococcus acidilactici Source : Pediococcus acidilactici - Whole Cell | 1 Milliards d'UFC | Not calculated |
| Pediococcus acidilactici Source : KABP-021 | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Hypromellose, Ascorbate de sodium, Dextrose, Maltodextrine, D-Mannitol, Trehalose, Citrate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Help improves quality of life in patients with diarrhea-predominant irritable bowel syndrome. Helps improve quality of life by relieving IBS symptoms. Helps reduce symptoms of lactose intolerance such as abdominal pain and flatulence. Helps relief symptoms of irritable bowel syndrome (IBS). Helps improve IBS-related quality of life in patients with IBS and diarrhea. Helps to manage patients' IBS symptoms that impacts their quality of life. Helps improve quality of life in IBS patients by supporting gut health and improving gut comfort. Helps to improve IBS gut-related stress/discomfort in 6 weeks.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80128802
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.